期刊文献+

慢性阻塞性肺疾病患者血清IL-17水平变化及其临床意义 被引量:1

The level change and clinical significance of IL-17 in the patient with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者血清白细胞介素-17(IL-17)水平变化及其临床意义。方法选择COPD患者90例(COPD组),按肺功能结果又分为轻度亚组、中度亚组、重度亚组各30例;另选健康志愿者30例作为对照组。采用酶联免疫吸附法(ELISA法)测定各组血清中IL-17水平;采用Pearson相关分析各组血清IL-17水平与相应第一秒用力呼气容积占预计值百分比(FEV1%)的相关性;比较2组外周血白细胞分类计数。结果COPD组血清IL-17水平均高于对照组;且COPD组血清IL-17水平随病情加重而增高,中度亚组、重度亚组血清IL-17水平高于轻度亚组,差异有统计学意义(P<0.05)。Pearson相关分析显示,COPD组血清IL-17水平与FEV1%呈负相关(r=-0.781,P<0.05)。COPD组中性粒细胞计数和淋巴细胞计数均明显高于对照组,差异均有统计学意义(P<0.05)。结论血清IL-17水平变化可作为判定COPD病情严重程度的指标之一。 Objective To explore the level change and clinical significance of IL-17 in the patient with chronic obstructive pulmonary disease.Methods 90 cases patients with chronic obstructive pulmonary disease(COPD) group were divided into mild group,moderate group and severe group according to the pulmonary function,each of 30 cases.Elected 30 cases of healthy volunteers as control group.Determined the level of IL-17 by ELISA in all groups.Analysised the relevance between FEV1% and the level of IL-17.Compared the count of peripheral blood leukocytes of two group.Results The level of IL-17 in serum of all kinds of COPD group were higher than that of contral group,and it increased with sicker,the level of IL-17 in the moderate group and the severe group were both higher than that of mild group,the difference were statistically significant(P〈0.05).Pearson correlation analysis showed that there was a negative correlation between FEV1% and the level of IL-17(r=-0.781,P〈0.05).The neutrophil count and lymphocyte count of COPD group were higher than that of contral group,the difference were statistically significant(P〈0.05).Conclusion The level of IL-17 in serum can be one of indicators in the judgement of the severity of chronic obstructive pulmonary disease.
出处 《临床合理用药杂志》 2013年第4期9-10,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 慢性阻塞性肺疾病 白细胞介素-17 肺功能 Chronic obstructive pulmonary disease Interleukin-17 Lung function
  • 相关文献

参考文献6

二级参考文献22

  • 1沈锋,赵鸣武,贺蓓,王玉柱,姚婉贞.慢性阻塞性肺疾病和支气管哮喘患者诱导痰中白细胞介素-17水平及其意义[J].中华内科杂志,2004,43(12):888-890. 被引量:27
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 4[3]Borrill ZL,fitarkey RC,Singh SD.Variability of exhaled breath condensate lenkotriene B4 and 8-isoprostane in COPD patients[J].Int J Chron Obstruct Pulmon Dis,2007,2(1):71-76.
  • 5[4]Hacievliyagil SS,Gunen H,Mudu LC,et al.Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease[J].Respir Med,2006,100(5):846-854.
  • 6[5]Miyamoto M,Prause O,Sjstrand M,et al.Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways[J].J Immunol,2003,170(9):4665-4672.
  • 7[6]Laan M,Cui ZH,Hoshino H,et al.Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways[J].J lmmunol,1999,162(4):2347-2352.
  • 8[7]Henness S,Johnson CK,Ge Q,et al.IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability[J].J Allergy Clin Immunol,2004,114(4):958-964.
  • 9[8]Jones CE,Chan K.Interleukin-17 stimulates the expression of interleukin-8,growth-related oncogene--alpha,end granulocyte-colony-sdimulating factor by human airway epithelial calls[J].Am J Respir Cell Mol Biol,2002,26(6):748-753.
  • 10[9]Barczyk A,Pierzchala W,Sozaska E.Interlenkin-17 in sputum correlates with airway hyperresponsiveness to methacholins[J].Respir Med,2003,97(6):726-733.

共引文献8253

同被引文献25

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部